Cepheid (NASDAQ:CPHD)

CAPS Rating: 2 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Recs

0
Player Avatar pchop123 (76.53) Submitted: 6/18/2012 3:40:45 PM : Outperform Start Price: $40.54 CPHD Score: +9.23

this is speculation I must admit, but do not bet against the IRISH

Featured Broker Partners


Advertisement